Johnson & Johnson kicked off U.S. human safety trials for its COVID-19 vaccine Thursday after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.  When exposed to the virus, six out of six animals who got the vaccine candidate